These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 29085971)

  • 1. [Not Available].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1274-1297. PubMed ID: 29085971
    [No Abstract]   [Full Text] [Related]  

  • 2. [Not Available].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1270-1273. PubMed ID: 29085970
    [No Abstract]   [Full Text] [Related]  

  • 3. [European drug agency and drug management].
    Barfuss W
    Leber Magen Darm; 1996 Jul; 26(4):191-2. PubMed ID: 8965600
    [No Abstract]   [Full Text] [Related]  

  • 4. [Critical aspects of current methadone treatment in Germany].
    Wagner-Servais D
    Dtsch Med Wochenschr; 2001 Mar; 126(10):275-8. PubMed ID: 11285763
    [No Abstract]   [Full Text] [Related]  

  • 5. [IQWiG in dialog 2013: "Significance of instituting benefit assessment"].
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(6):421. PubMed ID: 24075684
    [No Abstract]   [Full Text] [Related]  

  • 6. [Increased legal liability in off-label use].
    Broglie M
    Aktuelle Urol; 2006 Nov; 37(6):417-9. PubMed ID: 17153265
    [No Abstract]   [Full Text] [Related]  

  • 7. [Off-label use in psychopharmacotherapy].
    Fritze J; Schmauss M
    Nervenarzt; 2002 Aug; 73(8):796-9. PubMed ID: 12242971
    [No Abstract]   [Full Text] [Related]  

  • 8. [Negative would be welcome. The question is whose brain child this is].
    Hakimi R
    MMW Fortschr Med; 2006 Nov; 148(44):8. PubMed ID: 17632867
    [No Abstract]   [Full Text] [Related]  

  • 9. [About science and politics].
    Erdmann E
    Dtsch Med Wochenschr; 2003 Apr; 128(15):789. PubMed ID: 12690571
    [No Abstract]   [Full Text] [Related]  

  • 10. [The Therapeutic Drug Committee of German Physicians. 50 years in the service of drug safety in Germany].
    Müller-Oerlinghausen B; Tiaden JD
    Internist (Berl); 2002 Apr; 43(4):482, 485-92. PubMed ID: 12053404
    [No Abstract]   [Full Text] [Related]  

  • 11. [Off-label use in psychopharmacotherapy. Letter to Federal Minister Ulla Schmidt, Pulheim, 22 January 2003].
    Fritze J
    Nervenarzt; 2003 Apr; 74(4):389; discussion 390. PubMed ID: 12800838
    [No Abstract]   [Full Text] [Related]  

  • 12. [Does red-green destroy phytotherapy?].
    Krankenpfl J; 2003; 41(4-6):111. PubMed ID: 12929322
    [No Abstract]   [Full Text] [Related]  

  • 13. [Legal dispute about the black drug list. Irrespective of positive or negative list--I am in favor].
    Thöns M
    MMW Fortschr Med; 2006 Oct; 148(40):8. PubMed ID: 17338085
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical Trials with Medicinal Products : Changes imposed by the new Clinical Trial Regulation].
    Sudhop T; Krafft H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Aug; 60(8):793-794. PubMed ID: 28748294
    [No Abstract]   [Full Text] [Related]  

  • 15. [The significance of the list of prescribable drugs (so-called positive list) for psychopharmacotherapy].
    Fritze J; Schmauss M; Holsboer F;
    Nervenarzt; 2003 Feb; 74(2):195-7. PubMed ID: 12683388
    [No Abstract]   [Full Text] [Related]  

  • 16. [Open letter to minister of health. Toad medicine].
    Erdmann E
    Krankenpfl J; 2003; 41(4-6):110-1. PubMed ID: 12929321
    [No Abstract]   [Full Text] [Related]  

  • 17. [How AMOG limits the supply of diabetes drugs].
    Oberhofer E
    MMW Fortschr Med; 2015 Aug; 157(14):24. PubMed ID: 26289868
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cannabis in medicine. Legal aspects].
    Wartensleben H
    Schmerz; 2004 Dec; 18 Suppl 2():S34-5. PubMed ID: 23570089
    [No Abstract]   [Full Text] [Related]  

  • 19. [Off-label prescriptions. Drug use outside of established guidelines and treatment standard].
    Weissbach L; Boedefeld EA
    Urologe A; 2003 Mar; 42(3):428-32. PubMed ID: 12723544
    [No Abstract]   [Full Text] [Related]  

  • 20. [The physician caught between two chairs. Comments on the difficulty in dealing with off-label use].
    Harder Yv
    Urologe A; 2007 Oct; 46(10):1429-34. PubMed ID: 17786403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.